That rise came despite the approval of Merck & Co's 15-valent Vaxneuvance in July 2021, which has posed the first major challenge to the Prevnar family. With ASP3772, GSK could offer a shot with ...
The franchise brought in $6.4 billion in worldwide sales last year, although MSD (known as Merck & Co in the US and Canada) has started to claim market share with Vaxneuvance, which covers 15 ...
After hours: March 11 at 4:05:06 PM EDT Loading Chart for LGND ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback